Clinical Efficacy of Placentrex Injection in Pelvic Inflammatory Disease
Journal Title: Indian Journal of Obstetrics and Gynecology Research - Year 2016, Vol 3, Issue 1
Abstract
Pelvic inflammatory disease (PID) is one of the most frequent infections seen in reproductive age group and is associated with major clinical and pelvic health problem. It is Infection & inflammation of upper genital tract organs typically involving fallopian tubes, ovaries & surrounding structures. PID is polymicrobial in nature and is associated with different etiological agents. Clinical presentations may vary from mild to severe. No specific signs and symptoms are pathognomic of PID. Laboratory tests are also poor predictors of PID. There may be subclinical symptoms and patient later may present with infertility. CDC recommends treatment for even mild cases of PID. Therapeutic goal in management of PID is to prevent chronic residual disease. Failure of antibiotic therapy to prevent sequelae of salpingitis reflects the emphasis of additional therapy along with antibiotics. Placentrex is a drug containing Peptides (FNP-III, CRF), Nucleotides (PDRN) & Glutamate and is derived from an extract of fresh term, healthy, human placenta. It has significant anti inflammatory effect involving chemical mediators of immunological response. Effect of placentrex is well documented in wound healing1 and in treatment of burns and radiation effects 2. It has been recommended for prescription for PID but there is not much data in literature regarding the efficacy in PID. So we conducted a trial to find efficacy of placentrex in comparision with azithromycin for the treatment of PID.
Authors and Affiliations
Prameela Prameela, Kavya D Sharma
Prevalence of poly cystic ovarian syndrome among students of a tertiary care teaching hospital
Purpose of Study India already has highest number of patients with type 2 diabetes mellitus globally and rapid rise of the incidence of obesity in children is the prime reason for increasing insulin resistance the metabo...
Evaluation of effect of vitamin D supplementation on vitamin D levels and pregnancy outcome
Introduction Vitamin D is a fatsoluble vitamin which comes primarily from exposure to sunlight and only few foods acts as a source of it Vitamin D deficiency is a preventable health problem Research shows that during pre...
Evaluation of first trimester fasting blood glucose as a predictor of gestational diabetes mellitus
Background: Our goal was to find association between first trimester fasting blood sugar value compared with the second trimester oral glucose tolerance test value (75gm DIPSI criteria) for diagnosis of GDM. To find the...
Hypothyroidism in Pregnancy: A Hospital based cross sectional study
Introduction: Uncontrolled hypothyroidism is associated with serious maternal, fetal, and neonatal morbidity, and mortality. Overt hypothyroidism is defined as a clinical syndrome of hypothyroidism associated with elevat...
Antenatal Sonographic Diagnosis of Patau Syndrome (Trisomy 13): A Case Report
Patau syndrome is caused by an extra copy of chromosome 13, a medium acrocentric chromosome. In Malaysia, the incidence of Patau syndrome is 2.6/10,000 births. We report a case of Patau syndrome in thirty-two years old,...